Athena Diagnostics Newswire

Athena Diagnostics Newswire

Comprehensive Real-Time News Feed for Athena Diagnostics.

Results 1 - 20 of 801 in Athena Diagnostics

  1. How has Quest Diagnostics Inc.:(NYSE:DGX) performed recently?Read the original story w/Photo

    17 hrs ago | The Daily Leicester

    Quest Diagnostics Inc. is a large market cap stock with a market cap of 12199.33. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 16.53, a forward P/E of 15.73 and EPS of 5.16.

    Comment?

  2. More than half of adults misuse medications, study findsRead the original story w/Photo

    21 hrs ago | Daily Journal/Sunday Journal

    More than half of adults and 44 percent of children who were drug-tested by a national clinical laboratory last year misused their prescription medications, according to a study released Monday by Quest Diagnostics. Misuse of medications can mean patients were either taking too much, too little or none of their medications.

    Comment?

  3. Quest Diagnostics Inc. (DGX) Sets New 1-Year High at $85.16Read the original story w/Photo

    Thursday | Daily Political

    Quest Diagnostics Inc. 's share price hit a new 52-week high on Thursday . The stock traded as high as $85.16 and last traded at $85.11, with a volume of 393,127 shares changing hands.

    Comment?

  4. Doctors weigh in on Theranos: 'I want Elizabeth Holmes to have every benefit of the doubt'Read the original story w/Photo

    Thursday | Silicon Alley Insider

    I have no direct insight into the operations of the blood diagnostic company Theranos, and I've never met Elizabeth Holmes. The positioning of Holmes as "The Next Steve Jobs" and a $9 billion valuation certainly set her up for a nasty fall.

    Comment?

  5. Quest Diagnostics Inc. (DGX) Director John B. Ziegler Sells 1,000 Shares of StockRead the original story w/Photo

    Thursday | Daily Political

    Quest Diagnostics Inc. Director John B. Ziegler sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, July 25th. The stock was sold at an average price of $84.36, for a total transaction of $84,360.00.

    Comment?

  6. Study: More than half of adults misuse medicationsRead the original story w/Photo

    Thursday | WTNH

    The study was done by Quest Diagnostics and found that 54 percent of adults reported misusing their prescription medications last year. That number is slightly higher than it was in 2014.

    Comment?

  7. 164,700 Shares in Quest Diagnostics Inc. (DGX) Acquired by Adage Capital Partners GP L.L.C.Read the original story w/Photo

    Tuesday Jul 26 | Daily Political

    Adage Capital Partners GP L.L.C. purchased a new stake in shares of Quest Diagnostics Inc. during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm purchased 164,700 shares of the company's stock, valued at approximately $11,768,000.

    Comment?

  8. Study: Half of American Adults Misuse Their Prescription DrugsRead the original story

    Tuesday Jul 26 | P&T Community

    Most American adults taking opioids and other commonly prescribed medications use them in ways that put their health at risk, including potentially dangerous combinations with other drugs, according to a new study from Quest Diagnostics. The multiyear analysis of more than three million test results showed that 54% of patients tested in 2015 had evidence of drug misuse, slightly above the 53% misuse rate in 2014.

    Comment?

  9. Zacks Investment Research Upgrades Quest Diagnostics Inc. (DGX) to "Buy"Read the original story w/Photo

    Tuesday Jul 26 | Daily Political

    The firm currently has a $94.00 price target on the stock. Zacks Investment Research's price target would suggest a potential upside of 11.31% from the stock's previous close.

    Comment?

  10. More than half of adults are misusing their medications, study findsRead the original story w/Photo

    Monday Jul 25 | St. Petersburg Times

    More than half of adults and 44 percent of children who were drug-tested by a national clinical laboratory last year misused their prescription medications, according to a study released Monday by Quest Diagnostics. Misuse of medications can mean that patients were either taking too much, too little or none of their medications.

    Comment?

  11. Today's Top Gainers in the Market Quest Diagnostics Inc. (NYSE:DGX) from HealthcareRead the original story w/Photo

    Monday Jul 25 | The Daily Leicester

    Today's top gainers include the company Quest Diagnostics Inc. which is in the industry Medical Laboratories & Research , gaining -0.64% today. In the last week its performance is 2.04%, and 13.44% for the past quarter.

    Comment?

  12. Margins Are Key For NeoGenomics In Q2 2016Read the original story w/Photo

    Monday Jul 25 | Seeking Alpha

    NeoGenomics is set to release its 2Q'16 earnings report Tuesday morning July 26, 2016. NEO made a huge splash in the Cancer diagnostic world last year when it acquired Clarient.

    Comment?

  13. Quest Diagnostics Inc. (DGX) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    Monday Jul 25 | Daily Political

    According to Zacks, "Ahead of earning release, Quest Diagnostics expects seventh consecutive quarter of organic growth. Keeping in line with its five-point strategy, Quest Diagnostics is refocusing on core diagnostic information services business through product launch and strategic alliances and is also working on delivering disciplined capital deployment.

    Comment?

  14. Quest Diagnostics Inc. (DGX) Expected to Earn Q3 2016 Earnings of $1.36 Per ShareRead the original story w/Photo

    Monday Jul 25 | Daily Political

    Quest Diagnostics Inc. - Research analysts at Jefferies Group reduced their Q3 2016 earnings per share estimates for shares of Quest Diagnostics in a report released on Thursday. Jefferies Group analyst B. Tanquilut now expects that the firm will earn $1.36 per share for the quarter, down from their previous forecast of $1.40.

    Comment?

  15. Quest Diagnostics Inc. to Post Q3 2016 Earnings of $1.34 Per Share, SunTrust Banks ForecastsRead the original story w/Photo

    Monday Jul 25 | AmericanBankingNews.com

    Quest Diagnostics Inc. - SunTrust Banks lowered their Q3 2016 EPS estimates for shares of Quest Diagnostics in a report issued on Thursday. SunTrust Banks analyst D. Macdonald now anticipates that the firm will post earnings per share of $1.34 for the quarter, down from their previous forecast of $1.35.

    Comment?

  16. Quest Diagnostics Inc. Expected to Post Q3 2016 Earnings of $1.35 Per ShareRead the original story w/Photo

    Monday Jul 25 | AmericanBankingNews.com

    Quest Diagnostics Inc. - Equities researchers at Craig Hallum decreased their Q3 2016 earnings per share estimates for Quest Diagnostics in a note issued to investors on Friday. Craig Hallum analyst B. Bonello now expects that the firm will post earnings per share of $1.35 for the quarter, down from their prior forecast of $1.38.

    Comment?

  17. Quest Diagnostics Inc. (DGX) Stock Rating Reaffirmed by Evercore ISIRead the original story w/Photo

    Sunday Jul 24 | Daily Political

    Evercore ISI currently has a $89.50 price target on the stock, up from their previous price target of $78.50. DGX has been the topic of several other reports.

    Comment?

  18. Evercore ISI Reaffirms Hold Rating for Quest Diagnostics Inc.Read the original story w/Photo

    Sunday Jul 24 | AmericanBankingNews.com

    's stock had its "hold" rating restated by Evercore ISI in a research note issued on Sunday. They presently have a $89.50 price target on the stock, up from their prior price target of $78.50.

    Comment?

  19. United States Carcinoembryonic Antigen Market to Grow at a CAGR of...Read the original story

    Sunday Jul 24 | Emailwire.com

    United States Carcinoembryonic Antigen Market to Grow at a CAGR of 16.56% between 2016 and 2021 According to New Research Report 'United States Carcinoembryonic Antigen Industry 2016 Market Research Report' Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. United States Carcinoembryonic Antigen Market is expected to rise in 2016.

    Comment?

  20. Quest Diagnostics Inc. (DGX) Position Increased by National Pension ServiceRead the original story w/Photo

    Friday Jul 22 | Daily Political

    National Pension Service increased its stake in shares of Quest Diagnostics Inc. by 4.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,171 shares of the company's stock after buying an additional 4,535 shares during the period.

    Comment?